Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telemedicine Extended-release Buprenorphine in Jail
NCT07524738Phase 3Active, not recruiting
- Sponsor
- Friends Research Institute
- Start
- Jun 2025
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of buprenorphine in opioid use disorder (OUD), sponsored by Friends Research Institute. Primary endpoint: Medication Adherence. Started Jun 2025; status: active, not recruiting.
02
Drugs
buprenorphine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT07524738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07524738.